These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 4157329)

  • 21. Effect of repeated L-DOPA, bromocriptine, or lisuride administration on preproenkephalin-A and preproenkephalin-B mRNA levels in the striatum of the 6-hydroxydopamine-lesioned rat.
    Henry B; Crossman AR; Brotchie JM
    Exp Neurol; 1999 Feb; 155(2):204-20. PubMed ID: 10072296
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo neurochemical effects of the NR2B selective NMDA receptor antagonist CR 3394 in 6-hydroxydopamine lesioned rats.
    Sarre S; Lanza M; Makovec F; Artusi R; Caselli G; Michotte Y
    Eur J Pharmacol; 2008 Apr; 584(2-3):297-305. PubMed ID: 18342306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Role of adreno- and dopamine-reactive systems in the central action of caffeine].
    Kurbat NM; Korablev MV
    Farmakol Toksikol; 1981; 44(5):559-61. PubMed ID: 7198054
    [No Abstract]   [Full Text] [Related]  

  • 24. Loss of D1/D2 dopamine receptor synergisms following repeated administration of D1 or D2 receptor selective antagonists: electrophysiological and behavioral studies.
    Hu XT; White FJ
    Synapse; 1994 May; 17(1):43-61. PubMed ID: 7913772
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Catecholaminergic activation of G-protein coupling in rat spinal cord: further evidence for the existence of dopamine and noradrenaline receptors in spinal grey and white matter.
    Venugopalan VV; Ghali Z; Sénécal J; Reader TA; Descarries L
    Brain Res; 2006 Jan; 1070(1):90-100. PubMed ID: 16423330
    [TBL] [Abstract][Full Text] [Related]  

  • 26. L-DOPA-induced activation of striatal p38MAPK and CREB in neonatal dopaminergic denervated rat: relevance to self-injurious behavior.
    Sivam SP; Pugazhenthi S; Pugazhenthi V; Brown H
    J Neurosci Res; 2008 Feb; 86(2):339-49. PubMed ID: 17893915
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Repeated amphetamine administration: role of forebrain in reduced responsiveness of nigrostriatal dopamine neurons to dopamine agonists.
    Pitts DK; Kelland MD; Freeman AS; Chiodo LA
    J Pharmacol Exp Ther; 1993 Feb; 264(2):616-21. PubMed ID: 8094749
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhancement by 6-hydroxydopamine of the effects of DOPA upon the motor activity of rats.
    Schoenfeld RI; Uretsky NJ
    J Pharmacol Exp Ther; 1973 Sep; 186(3):616-24. PubMed ID: 4728340
    [No Abstract]   [Full Text] [Related]  

  • 29. Dopamine analog-induced hyperglycemia in rats: involvement of the adrenal medulla and the endocrine pancreas.
    Arnerić SP; Chow SA; Long JP; Fischer LJ
    J Pharmacol Exp Ther; 1984 Mar; 228(3):551-9. PubMed ID: 6142939
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pre- and postsynaptic actions of a partial D2 receptor agonist in reserpinized young rats: longevity of agonistic effects.
    Farley CM; Baella SA; Wacan JJ; Crawford CA; McDougall SA
    Brain Res; 2006 Dec; 1124(1):37-44. PubMed ID: 17070785
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Repeated administrations of dopamine receptor agents affect lithium-induced state-dependent learning in mice.
    Zarrindast M; Madadi F; Ahmadi S
    J Psychopharmacol; 2009 Aug; 23(6):645-51. PubMed ID: 18635706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The search for compounds with dopaminergic action. V. Synthesis of piribedil analogs].
    Woliński J; Kujawa T
    Acta Pol Pharm; 1987; 44(2):143-6. PubMed ID: 2893511
    [No Abstract]   [Full Text] [Related]  

  • 33. Piribedil could modify dopamine turnover in cochleas under noise stimulation.
    Vicente-Torres MA; Gil-Loyzaga P; Fernández P; Arce A; Esquifino A
    ORL J Otorhinolaryngol Relat Spec; 1993; 55(6):322-4. PubMed ID: 8265115
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The search for compounds with dopaminergic activity. VII. Synthesis of piribedil analogs].
    Woliński J; Kujawa T; Prokopienko G; Rafalska B
    Acta Pol Pharm; 1988; 45(3):206-9. PubMed ID: 3239429
    [No Abstract]   [Full Text] [Related]  

  • 35. [Current developments in the pharmacology of dopaminergic receptors (I)].
    Nechifor M; Lucaci L
    Rev Med Chir Soc Med Nat Iasi; 1989; 93(1):143-4. PubMed ID: 2573121
    [No Abstract]   [Full Text] [Related]  

  • 36. Investigation of the relationship between some brain peptides and neurotransmitters.
    Barbeau A; Burnett C; Strother E; Belanger F; Butterworth RF
    Int J Neurol; 1979; 13(1-4):157-65. PubMed ID: 45446
    [No Abstract]   [Full Text] [Related]  

  • 37. Weight change during various neuropharmacologic manipulations in psychotic inpatients.
    Carman JS; Wyatt RJ; Nasrallah HA; O'Brien P; Gillin JC
    Acta Cient Venez; 1978; 29(3):178-80. PubMed ID: 757726
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of hypothermia on the response of isolated rat myocardium to xanthine derivatives.
    Price JM; Nayler WG
    Arch Int Pharmacodyn Ther; 1967 Apr; 166(2):390-7. PubMed ID: 6032963
    [No Abstract]   [Full Text] [Related]  

  • 39. Intrinsic activity of DA agonists.
    Lahti RA; Figur LM; Piercey MF; Ruppel PL; Evans DL
    Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():182A-183A. PubMed ID: 1354024
    [No Abstract]   [Full Text] [Related]  

  • 40. Dopaminergic drugs in the cationic form interact with D2 dopamine receptors.
    Miller DD; Harrold M; Wallace RA; Wallace LJ; Uretsky NJ
    Trends Pharmacol Sci; 1988 Aug; 9(8):282-4. PubMed ID: 2907954
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.